Botanix Pharmaceuticals Limited (BOT.AX)
AUD 0.39
(1.3%)
AUD 0.39
(1.3%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.12 Million | -12.07 Million | -11.18 Million | -2.96 Million | -17.35 Million | -13.14 Million |
| Net Income | -13.86 Million | -9.15 Million | -13.17 Million | -3.33 Million | -16.73 Million | -17.03 Million |
| Depreciation & Amortization | 72.6 Thousand | 110.43 Thousand | 143.49 Thousand | 94.22 Thousand | 102.28 Thousand | 1581.00 |
| Deferred income taxes | - | -6.29 Million | 887.8 Thousand | -1.05 Million | -5.59 Million | -759.12 Thousand |
| Stock-based compensation | 4.39 Million | 1.52 Million | 334.19 Thousand | 568.38 Thousand | 2.32 Million | 815.75 Thousand |
| Change in working capital | -660.9 Thousand | -4.55 Million | 1.5 Million | -296.63 Thousand | -3.05 Million | -56.63 Thousand |
| Other non-cash items | 1.93 Million | 6.29 Million | -887.8 Thousand | 1.05 Million | 5.59 Million | 3.89 Million |
| Investing Cash Flow | -17.99 Million | -7.05 Million | -2.92 Million | -8281.00 | -151.19 Thousand | -13.28 Thousand |
| Investments in PPE | -17.99 Million | -7.05 Million | -2.92 Million | -8281.00 | -90.05 Thousand | -13.28 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -17.88 Million | -7.04 Million | -2.91 Million | - | -61.14 Thousand | - |
| Financing Cash Flow | 95.09 Million | 22.02 Million | -152.41 Thousand | -125.5 Thousand | 37.3 Million | 568.64 Thousand |
| Debt repayment | - | -1.84 Million | -152.41 Thousand | -125.5 Thousand | -23.07 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5.75 Million | -1.43 Million | - | - | -3.15 Million | -26.75 Thousand |
| Common Stock Issuance | 100.85 Million | 22.15 Million | - | - | 37.33 Million | 568.64 Thousand |
| Other Financing Activities | 95.09 Million | 4.48 Million | -152.41 Thousand | -125.5 Thousand | 37.3 Million | 26.75 Thousand |
| Accounts receivables | -2.34 Million | -409.98 Thousand | -96.79 Thousand | 85.1 Thousand | 351.15 Thousand | -56.63 Thousand |
| Accounts payables | 1.93 Million | -4.03 Million | 4.65 Million | -381.74 Thousand | -3.4 Million | 3.11 Million |
| Inventory | 1.68 Million | -102.68 Thousand | -3.04 Million | - | - | - |
| Other working capital | - | - | - | - | - | -3.11 Million |
| Cash at beginning of period | 10.25 Million | 7.28 Million | 21.55 Million | 24.64 Million | 4.7 Million | 17.26 Million |
| Cash at end of period | 79.3 Million | 10.25 Million | 7.28 Million | 21.55 Million | 24.64 Million | 4.7 Million |
| Capital Expenditure | -17.99 Million | -7.05 Million | -2.92 Million | -8281.00 | -90.05 Thousand | -13.28 Thousand |
| Effect of forex changes on cash | 86.16 Thousand | 62.94 Thousand | -10.91 Thousand | 11.52 Thousand | 142.52 Thousand | 26.41 Thousand |
| Net cash flow / Change in cash | 69.05 Million | 2.96 Million | -14.26 Million | -3.09 Million | 19.94 Million | -12.55 Million |
| Free Cash Flow | -26.12 Million | -19.12 Million | -14.1 Million | -2.97 Million | -17.44 Million | -13.15 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.4 Million | -13.86 Million | -5.46 Million | -9.15 Million | -4.55 Million | -4.59 Million |
| Depreciation & Amortization | 64.17 Thousand | 72.6 Thousand | 8431.00 | 110.43 Thousand | 93.6 Thousand | 16.82 Thousand |
| Deferred income taxes | - | - | - | -6.29 Million | -460.03 Thousand | - |
| Stock-based compensation | 2.89 Million | - | 1.49 Million | 1.52 Million | 785.49 Thousand | 735.33 Thousand |
| Change in working capital | -660.9 Thousand | - | - | -4.55 Million | -512.67 Thousand | - |
| Other non-cash items | 1.73 Million | 5.81 Million | 1.71 Million | 6.29 Million | -1.69 Million | -1.11 Million |
| Investing Cash Flow | -3.22 Million | -17.99 Million | -14.77 Million | -7.05 Million | -1.94 Million | -5.11 Million |
| Investments in PPE | -76.52 Thousand | -17.99 Million | -14.77 Million | -7.05 Million | -1.94 Million | -5.11 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.14 Million | - | -14.73 Million | -7.04 Million | -1.93 Million | -5.1 Million |
| Financing Cash Flow | 68.34 Million | 95.09 Million | 26.75 Million | 22.02 Million | 9.48 Million | 12.54 Million |
| Debt repayment | - | - | - | -1.84 Million | -1.84 Million | -89.99 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1.43 Million | - | - |
| Common Stock Issuance | 68.34 Million | 95.09 Million | 26.75 Million | 22.15 Million | 9.51 Million | 12.63 Million |
| Other Financing Activities | 68.34 Million | - | 26.75 Million | 4.48 Million | 1.84 Million | 12.63 Million |
| Accounts receivables | -2.34 Million | - | - | -409.98 Thousand | -409.98 Thousand | - |
| Accounts payables | - | - | - | -4.03 Million | - | - |
| Inventory | 1.68 Million | - | - | -102.68 Thousand | -102.68 Thousand | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 18.31 Million | 10.25 Million | 10.25 Million | 7.28 Million | 8.71 Million | 7.28 Million |
| Cash at end of period | 79.3 Million | 79.3 Million | 18.31 Million | 10.25 Million | 10.25 Million | 8.71 Million |
| Capital Expenditure | -76.52 Thousand | -17.99 Million | -14.77 Million | -7.05 Million | -1.94 Million | -5.11 Million |
| Effect of forex changes on cash | 244.4 Thousand | - | -158.24 Thousand | 62.94 Thousand | 336.75 Thousand | -273.8 Thousand |
| Net cash flow / Change in cash | 60.99 Million | 69.05 Million | 8.06 Million | 2.96 Million | 1.53 Million | 1.43 Million |
| Free Cash Flow | -4.44 Million | -26.12 Million | -18.53 Million | -19.12 Million | -8.28 Million | -10.84 Million |
MOMT
3763
6140
EQT
NED
2053